Published in Med Care on June 01, 2007
Multiple sclerosis patients' benefit-risk preferences: serious adverse event risks versus treatment efficacy. J Neurol (2009) 1.67
Medication preferences and adherence among individuals with severe mental illness and psychiatric advance directives. Psychiatr Serv (2010) 1.64
Online information seeking by patients with bipolar disorder: results from an international multisite survey. Int J Bipolar Disord (2016) 1.41
Predictors of nonadherence among individuals with bipolar disorder receiving treatment in a community mental health clinic. Compr Psychiatry (2008) 1.21
Review of the safety, efficacy, and side effect profile of asenapine in the treatment of bipolar 1 disorder. Patient Prefer Adherence (2011) 1.00
Patient Preferences for Injectable Treatments for Multiple Sclerosis in the United States: A Discrete-Choice Experiment. Patient (2016) 0.96
Effect of pill burden on dosing preferences, willingness to pay, and likely adherence among patients with type 2 diabetes. Patient Prefer Adherence (2013) 0.94
Medication treatment perceptions, concerns and expectations among depressed individuals with Type I Bipolar Disorder. J Affect Disord (2008) 0.92
Correlates of medication adherence among patients with bipolar disorder: results of the bipolar evaluation of satisfaction and tolerability (BEST) study: a nationwide cross-sectional survey. Prim Care Companion J Clin Psychiatry (2010) 0.87
Understanding rational non-adherence to medications. A discrete choice experiment in a community sample in Australia. BMC Fam Pract (2012) 0.85
Adaptive choice-based conjoint analysis: a new patient-centered approach to the assessment of health service preferences. Patient (2010) 0.85
What matters to patients? A systematic review of preferences for medication-associated outcomes in mental disorders. BMJ Open (2015) 0.84
Antidepressant dosage taken by patients with bipolar disorder: factors associated with irregularity. Int J Bipolar Disord (2013) 0.82
Adherence to Antipsychotic Medication in Bipolar Disorder and Schizophrenic Patients: A Systematic Review. J Clin Psychopharmacol (2016) 0.80
The Role of Qualitative Research Methods in Discrete Choice Experiments. Med Decis Making (2017) 0.79
Cost-effectiveness of asenapine in the treatment of bipolar disorder in Canada. BMC Psychiatry (2014) 0.77
The diagnosis and treatment of bipolar disorder: decision-making in primary care. Prim Care Companion CNS Disord (2014) 0.76
Correlates of attitudes towards mood stabilizers in individuals with bipolar disorder. Bipolar Disord (2014) 0.76
Treatment-adherence in bipolar disorder: A patient-centred approach. World J Psychiatry (2016) 0.75
Hospital treatment, mortality and healthcare costs in relation to socioeconomic status among people with bipolar affective disorder. BJPsych Open (2016) 0.75
Olanzapine is superior to lamotrigine in the prevention of bipolar depression: a naturalistic observational study. BMC Psychiatry (2014) 0.75
Difficult to swallow: patient preferences for alternative valproate pharmaceutical formulations. Patient Prefer Adherence (2009) 0.75
What influences persistence with medicines? A multinational discrete choice experiment of 2549 patients. Br J Clin Pharmacol (2016) 0.75
Adverse Drug Events in Patients with Mental Disorder in an Ambulatory Setting. Int J Appl Basic Med Res (2017) 0.75
Neuropsychological functioning, age, and medication adherence in bipolar disorder. PLoS One (2017) 0.75
Conjoint analysis applications in health--a checklist: a report of the ISPOR Good Research Practices for Conjoint Analysis Task Force. Value Health (2011) 5.12
Development and cross-sectional validation of the Childhood Asthma Control Test. J Allergy Clin Immunol (2007) 4.26
Prevalence and cost of nonadherence to antiepileptic drugs in elderly patients with epilepsy. Epilepsy Behav (2008) 1.85
Crohn's disease patients' risk-benefit preferences: serious adverse event risks versus treatment efficacy. Gastroenterology (2007) 1.71
Multiple sclerosis patients' benefit-risk preferences: serious adverse event risks versus treatment efficacy. J Neurol (2009) 1.67
Lean body mass-based standardized uptake value, derived from a predictive equation, might be misleading in PET studies. Eur J Nucl Med Mol Imaging (2002) 1.67
Restless legs syndrome (RLS) augmentation associated with dopamine agonist and levodopa usage in a community sample. Sleep Med (2011) 1.57
The impact of inadequately controlled asthma in urban children on quality of life and productivity. Ann Allergy Asthma Immunol (2007) 1.45
Patients' preferences for treatment outcomes for advanced non-small cell lung cancer: a conjoint analysis. Lung Cancer (2012) 1.44
High-risk individuals' willingness to pay for diabetes risk-reduction programs. Diabetes Care (2006) 1.41
Lamotrigine in the acute treatment of bipolar depression: results of five double-blind, placebo-controlled clinical trials. Bipolar Disord (2008) 1.38
How patient cost-sharing trends affect adherence and outcomes: a literature review. P T (2012) 1.37
How do physician assessments of patient preferences for colorectal cancer screening tests differ from actual preferences? A comparison in Canada and the United States using a stated-choice survey. Health Econ (2009) 1.27
Association of non-adherence to antiepileptic drugs and seizures, quality of life, and productivity: survey of patients with epilepsy and physicians. Epilepsy Behav (2008) 1.20
How does cost matter in health-care discrete-choice experiments? Health Econ (2011) 1.15
Are adult patients more tolerant of treatment risks than parents of juvenile patients? Risk Anal (2008) 1.13
Patients rank toxicity against progression free survival in second-line treatment of advanced renal cell carcinoma. J Med Econ (2012) 1.08
Patient benefit-risk preferences for targeted agents in the treatment of renal cell carcinoma. Pharmacoeconomics (2011) 1.04
Economic impact of generic substitution of lamotrigine: projected costs in the US using findings in a Canadian setting. Curr Med Res Opin (2008) 1.04
Lipoma arborescens; successfully treated by yttrium-90 radiosynovectomy. Ann Nucl Med (2003) 1.04
Adolescent and caregiver experiences with epilepsy. J Child Neurol (2009) 0.99
The economic consequences of generic substitution for antiepileptic drugs in a public payer setting: the case of lamotrigine. Dis Manag (2007) 0.97
Lamotrigine as add-on therapy in schizophrenia: results of 2 placebo-controlled trials. J Clin Psychopharmacol (2007) 0.97
Stated preferences of patients with cancer for health-related quality-of-life (HRQOL) domains during treatment. Qual Life Res (2006) 0.96
The relationship between health perception and utility in heart failure patients in a clinical trial: results from an OVERTURE substudy. J Card Fail (2004) 0.96
Quality of care associated with common chronic diseases in a 9-state Medicaid population utilizing claims data: an evaluation of medication and health care use and costs. Popul Health Manag (2010) 0.94
Hypothetical bias, cheap talk, and stated willingness to pay for health care. J Health Econ (2009) 0.94
The long-term dynamics of mortality benefits from improved water and sanitation in less developed countries. PLoS One (2013) 0.89
The effect of dermatologic precautions on the incidence of rash with addition of lamotrigine in the treatment of bipolar I disorder: a randomized trial. J Clin Psychiatry (2006) 0.89
The economic impact of opioids on postoperative pain management. J Clin Anesth (2002) 0.88
Patients' preferences for bone metastases treatments in France, Germany and the United Kingdom. Support Care Cancer (2014) 0.88
Iodine-131 treatment and chromosomal damage: in vivo dose-effect relationship. Eur J Nucl Med Mol Imaging (2004) 0.88
Quantifying women's stated benefit-risk trade-off preferences for IBS treatment outcomes. Value Health (2010) 0.88
Quality of care for veterans with chronic diseases: performance on quality indicators, medication use and adherence, and health care utilization. Popul Health Manag (2010) 0.86
The cost-effectiveness of lamotrigine in the maintenance treatment of adults with bipolar I disorder. J Manag Care Pharm (2006) 0.86
Maintenance treatment outcomes in older patients with bipolar I disorder. Am J Geriatr Psychiatry (2005) 0.86
A double-blind placebo-controlled trial of lamotrigine as an antidepressant augmentation agent in treatment-refractory unipolar depression. J Clin Psychiatry (2011) 0.86
Impact of lamotrigine and lithium on weight in obese and nonobese patients with bipolar I disorder. Am J Psychiatry (2006) 0.85
Predictors of bipolar disorder risk among patients currently treated for major depression. MedGenMed (2006) 0.85
How do physicians weigh benefits and risks associated with treatments in patients with osteoarthritis in the United Kingdom? J Rheumatol (2012) 0.85
Patients' benefit-risk preferences for chronic idiopathic thrombocytopenic purpura therapies. Ann Pharmacother (2010) 0.85
Comparative efficacy and cost of asthma care in children with asthma treated with fluticasone propionate and montelukast. J Pediatr (2007) 0.85
Patients' willingness to trade off between the duration and frequency of rheumatoid arthritis treatments. Arthritis Care Res (Hoboken) (2014) 0.84
Association between ABCB1 (MDR1) gene 3435 C>T polymorphism and colchicine unresponsiveness of FMF patients. Ren Fail (2011) 0.84
Alterations in promoter methylation status of tumor suppressor HIC1, SFRP2, and DAPK1 genes in prostate carcinomas. DNA Cell Biol (2011) 0.84
Comparing outcomes in patients with persistent asthma: a registry of two therapeutic alternatives. Curr Med Res Opin (2006) 0.84
Eliciting benefit-risk preferences and probability-weighted utility using choice-format conjoint analysis. Med Decis Making (2011) 0.84
Using the incremental net benefit framework for quantitative benefit-risk analysis in regulatory decision-making--a case study of alosetron in irritable bowel syndrome. Value Health (2009) 0.83
The validity and clinical utility of symptom monitoring in advanced lung cancer: a literature review. Clin Lung Cancer (2002) 0.82
Employee health and frequency of workers' compensation and disability claims. J Occup Environ Med (2009) 0.82
Risk factors for antiepileptic drug regimen change in patients with newly diagnosed epilepsy. Epilepsy Behav (2011) 0.82
Prospective, open-label trial measuring satisfaction and convenience of two formulations of lamotrigine in subjects with mood disorders. Patient Prefer Adherence (2013) 0.81
Using conjoint analysis to estimate healthy-year equivalents for acute conditions: an application to vasomotor symptoms. Value Health (2009) 0.81
The association between antiepileptic drug and HMG-CoA reductase inhibitor co-medication and cholesterol management in patients with epilepsy. Epilepsy Res (2010) 0.81
Are chemotherapy patients' HRQoL importance weights consistent with linear scoring rules? A stated-choice approach. Qual Life Res (2006) 0.80
Women's willingness to accept perceived risks for vasomotor symptom relief. J Womens Health (Larchmt) (2007) 0.80
Patients' willingness to accept the risks and benefits of new treatments for chronic hepatitis C virus infection. Patient (2012) 0.79
Who pays attention in stated-choice surveys? Health Econ (2010) 0.79
Adherence to treatment guidelines and therapeutic regimens: a US claims-based benchmark of a commercial population. Popul Health Manag (2010) 0.79
Economic burden associated with the use of generic antiepileptic drugs in the United States. Epilepsy Behav (2010) 0.79
Incidence and time course of subsyndromal symptoms in patients with bipolar I disorder: an evaluation of 2 placebo-controlled maintenance trials. J Clin Psychiatry (2006) 0.79
Zinc and copper status in acute pancreatitis: an experimental study. Biol Trace Elem Res (2003) 0.79
A large renal pelvic diverticulum, presenting incomplete excretion during tc-99m MAG-3 scintigraphy and tracer accumulation on tc-99m DMSA scintigraphy; a case report. Ann Nucl Med (2004) 0.78
Effects of simplifying choice tasks on estimates of taste heterogeneity in stated-choice surveys. Soc Sci Med (2009) 0.78
Patient preferences and linear scoring rules for patient-reported outcomes. Patient (2010) 0.78
The proto-oncogene KRAS and BRAF profiles and some clinical characteristics in colorectal cancer in the Turkish population. Genet Test Mol Biomarkers (2013) 0.78
Recurrence in bipolar I disorder: a post hoc analysis excluding relapses in two double-blind maintenance studies. Biol Psychiatry (2006) 0.78
Association Between ABCB1 (MDR1) Gene Polymorphism and Unresponsiveness Combined Therapy in Chronic Hepatitis C virus. Hepat Mon (2013) 0.78
Effect of heavy metals in the meconium on preterm mortality: preliminary study. Pediatr Int (2013) 0.78
Preoperative localization of parathyroid adenomas with technetium-99m methoxyisobutylisonitrile imaging: relationship with P-glycoprotein expression, oxyphilic cell content, and tumoral tissue volume. Cancer Biother Radiopharm (2006) 0.77
Erythrocyte osmotic fragility and lipid peroxidation in experimental hyperthyroidism. Endocrine (2009) 0.77
Seizure emergency plans: patient results from a cross-sectional epilepsy survey. Epilepsy Behav (2008) 0.77
Physicians' stated trade-off preferences for chronic hepatitis B treatment outcomes in Germany, France, Spain, Turkey, and Italy. Eur J Gastroenterol Hepatol (2012) 0.77
The effects of experimental hypothyroidism on hemorheology and plasma fibrinogen concentration. Endocrine (2005) 0.77
Health care resource utilization and costs associated with restless legs syndrome among managed care enrollees treated with dopamine agonists. Manag Care (2012) 0.76
Lithium-induced hypothyroidism: oxidative stress and osmotic fragility status in rats. Biol Trace Elem Res (2013) 0.76
The effects of chronic long-term intermittent hypobaric hypoxia on blood rheology parameters. Gen Physiol Biophys (2011) 0.76
The prevalence of VKORC1 1639 G>A and CYP2C9*2*3 genotypes in patients that requiring anticoagulant therapy in Turkish population. Mol Biol Rep (2012) 0.75
Preferences for Multiple Sclerosis Treatments: Using a Discrete-Choice Experiment to Examine Differences Across Subgroups of US Patients. Int J MS Care (2017) 0.75
Direct economic effect following mupirocin therapy failure among patients with uncomplicated skin and skin-structure infections in a large population-based cohort. Manag Care Interface (2007) 0.75
Migraine: a better way to recognize and treat it. J Fam Pract (2006) 0.75
Administration of ECT in a patient with an inoperable abdominal aortic aneurysm: serial imaging of the aorta during maintenance. J ECT (2003) 0.75
Evaluation of the relative importance of chemotherapeutic and antiemetic efficacy in various oncologic settings. Support Care Cancer (2008) 0.75